Stay updated with breaking news from Novaccess Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NovAccess Global Inc. (OTCMKTS:XSNX – Get Free Report) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 400 shares, a decline of 84.6% from the April 30th total of 2,600 shares. Based on an average daily trading volume, of 869,000 […]
NovAccess Global Announces New License to Advance its Immunotherapy Platform Cleveland, OH - April 30, 2024 -- NovAccess Global Inc. , a...
NovAccess Global Announces New License to Advance its Immunotherapy ...
Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) and NovAccess Global (OTCMKTS:XSNX – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations. Institutional & Insider Ownership 98.6% of Protagonist […]
NovAccess Global Inc. (OTCMKTS:XSNX – Get Free Report) was the target of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 400 shares, a drop of 85.7% from the December 31st total of 2,800 shares. Based on an average daily volume of 1,208,200 shares, […]